We are monitoring the impact of COVID-19 on North America Apheresis Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2965
Share on
Share on

North America Apheresis Market Research Report - Segmented By Product, Procedure, Application, Technology, End-User & Country (The United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2965
Pages: 165

North America Apheresis Market Size (2021 to 2026)

The Apheresis Market size in North America was worth USD 0.75 billion in 2021. It is estimated to be growing at a CAGR of 10.87% to reach USD 1.26 billion by 2026 during the forecast period.

The U.S. Government has supported R & D funding of Apheresis through its benefit programs such as Medicaid, Medicare, veterans’ health administration, military, and employee insurance programs. Medicare provides coverage for apheresis regardless of whether the procedure is performed in a hospital or a blood center. Besides, private insurers have recently begun to examine apheresis procedures and issue policy statements about coverage closely.

The rising aging population in North American countries like the United States and Canada is estimated to favor market growth during the forecast period. As per the statistics published by the U.S. Census Bureau, the number of Americans aged 65 years and above is expected to escalate from 46 million to 98 million by 2060. Y-O-Y growth in the incidence of hematologic diseases is predicted to accelerate the development of the North American apheresis market. Growing blood disorders incidence, using advanced technology machines for differentiating blood components is expected to support market growth.

In North America, the lack of donor availability and histocompatibility are expected to restrain the market growth. Risks and obstacles associated with the apheresis market may hamper the market growth during the period. Side effects with replacement fluids impede the growth. Lack of awareness and high cost hinders market growth.

This research report on the North America Apheresis Market has been segmented and sub-segmented into the following categories:

  • By Product: Devices and Disposables
  • By Procedure: Donor, Therapeutic, and Photopheresis
  • By Application: Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases, and Cardiovascular Diseases
  • By Technology: Centrifuge and Membrane Separation
  • By End User: Private Blood Collection Centres, Public Blood Collection Centres, and Hospitals
  • By Country: The United States, Canada, and Rest of North America

Regional Analysis:

As of 2019, North America leads the Global Apheresis market, accounting for more than 34% of the total market share. North America has the largest market in 2019 due to its healthcare infrastructure and high demand for plasma to produce plasma-derived medicines. The disposables products segment is expected to have the largest share in the North America apheresis market.

The United States is projected to lead the market in this region due to the growing number of apheresis methods and their enhancements, increasing the number of apheresis centers, and accepting well-developed infrastructure. Moreover, encouraging reimbursement policies and the possibility of developed blood collection technologies that bolster the market. 

Following the United States, the Canadian market is leading the North American region. An increasing number of substantial market players in the area augment research and development activities related to product manufacturing and marketing activities. Y-O-Y increase in chronic kidney diseases is to contribute more towards market growth. The surging number of transfusion services and around 71.9 per 1,000 individuals and nearly 4million are diagnosed with chronic kidney diseases.

Companies playing a dominant role in the North America Apheresis Market profiled in this report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.

1. Introduction           

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions                

2. Research Methodology                     

                2.1 Introduction         

                2.2 Research Phases

          2.2.1 Secondary Research           

          2.2.2 Primary Research 

          2.2.3 Econometric Modelling      

          2.2.4 Expert Validation  

                2.3 Analysis Design   

                2.4 Study Timeline    

3. Overview                 

                3.1 Executive Summary                

                3.2 Key Inferences   

                3.3 Epidemology        

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers    

                4.2 Market Restraints                    

                4.3 Key Challenges   

                4.4 Current Opportunities in the Market        

5. Market Segmentation  

                5.1 Product  

          5.1.1 Introduction           

          5.1.2 Apheresis devices

    5.1.2.1 Plasma separators

    5.1.2.2 Plasma component separators

    5.1.2.3 Immunoadsorption Columns

    5.1.2.4 Plasma Perfusion Columns

    5.1.2.5 Hemoperfusion Columns

          5.1.3 Apheresis disposables       

          5.1.4  Y-o-Y Growth Analysis, By Product              

          5.1.5  Market Attractiveness Analysis, By Product            

          5.1.6  Market Share Analysis, By Product              

                5.2 Procedure                   

          5.2.1 Introduction           

          5.2.2 Donor Apheresis  

          5.2.3 Therapeutic Apheresis       

          5.2.4 Y-o-Y Growth Analysis, By Procedure          

          5.2.5 Market Attractiveness Analysis, By Procedure        

          5.2.6 Market Share Analysis, By Procedure          

                5.3 Application                 

          5.3.1 Introduction           

          5.3.2 Renal Diseases      

          5.3.3 Neurology               

          5.3.4 Cancer      

          5.3.5 Hematology            

          5.3.6 Autoimmune Diseases       

          5.3.7 Cardiovascular Diseases    

          5.3.8 Y-o-Y Growth Analysis, By Application         

          5.3.9 Market Attractiveness Analysis, By Application       

          5.3.10 Market Share Analysis, By Application      

                5.4 Technology                 

          5.4.1 Centrifugation       

    5.4.1.1 Intermittent Flow

    5.4.1.2 Continuous Flow

          5.4.2 Membrane Separation      

          5.4.3 Y-o-Y Growth Analysis, By Technology        

          5.4.4  Market Attractiveness Analysis, By Technology     

          5.4.5  Market Share Analysis, By Technology       

                5.5 End user

          5.5.1 Introduction           

          5.5.2 Private Blood Collection Centres   

          5.5.3 Public Blood Collection Centres      

          5.5.4 Hospitals  

          5.4.5 Y-o-Y Growth Analysis, By End user              

          5.4.6  Market Attractiveness Analysis, By End user           

          5.4.7  Market Share Analysis, By End user            

6. Geographical Analysis  

                6.1 Introduction         

          6.1.1 Regional Trends    

          6.1.2 Impact Analysis     

          6.1.3 Y-o-Y Growth Analysis        

    6.1.3.1 By Geographical Area

    6.1.3.2 By Product

    6.1.3.3 By Procedure

    6.1.3.4 By Application

    6.1.3.5 By Technology

    6.1.3.6 By End user

          6.1.4  Market Attractiveness Analysis     

    6.1.4.1 By Geographical Area

    6.1.4.2 By Product

    6.1.4.3 By Procedure

    6.1.4.4 By Application

    6.1.4.5 By Technology

    6.1.4.6 By End user

          6.1.5  Market Share Analysis      

    6.1.5.1 By Geographical Area

    6.1.5.2 By Product

    6.1.5.3 By Procedure

    6.1.5.4 By Application

    6.1.5.5 By Itechnology

    6.1.5.6 By End user

                6.2 United States      

                6.3 Canada   

7. Strategic Analysis                 

                7.1 PESTLE analysis   

          7.1.1 Political     

          7.1.2 Economic 

          7.1.3 Social         

          7.1.4 Technological         

          7.1.5 Legal          

          7.1.6 Environmental       

                7.2 Porter’s Five analysis        

          7.2.1 Bargaining Power of Suppliers        

          7.2.2 Bargaining Power of Consumers    

          7.2.3 Threat of New Entrants     

          7.2.4 Threat of Substitute Products and Services              

          7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                  

                8.1 Asahi Kasei Medical Co., Ltd.         

          8.1.1 Overview 

          8.1.2 Product Analysis   

          8.1.3 Financial analysis  

          8.1.4 Recent Developments       

          8.1.5 SWOT analysis       

          8.1.6 Analyst View          

                8.2 Haemonetics Corporation                    

                8.3 Terumo BCT, Inc.

                8.4 Fresenius Medical Care   

                8.5 Kawasumi Laboratories Inc.                 

                8.6 Cerus Corporation                   

                8.7 Hemacare Corporation    

                8.8 Kaneka Corporation                

                8.9 Braun Melsungen AG       

                8.10 Nikkiso Co., Ltd.                     

                8.11 Therakos, Inc.,  

                8.12 Medica S.p.A.    

9. Competitive Landscape                     

                9.1 Market share analysis      

                9.2 Merger and Acquisition Analysis 

                9.3 Agreements, collaborations and Joint Ventures   

                9.4 New Product Launches   

10. Market Outlook and Investment Opportunities                   

Appendix                     

                a) List of Tables                

                b) List of Figures        

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Apheresis Market, By Product, From 2021 to 2026 (USD Million)
  2. North America Devices Market, By Region, From 2021 to 2026 (USD Million)
  3. North America Disposables Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Apheresis Market, By Procedure, From 2021 to 2026 (USD Million)
  5. North America Donor Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Therapeutic Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Apheresis Market, By Application, From 2021 to 2026 (USD Million)
  8. North America Renal Diseases Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Neurology Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Cancer Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Hematology Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Autoimmune Diseases  Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Apheresis Market, By Technology, From 2021 to 2026 (USD Million)
  15. North America Centrifuge separation Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Membrane Separation Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Apheresis Market, By End user, From 2021 to 2026 (USD Million)
  18. North America Private Blood Collection Centres Market, By Region, From 2021 to 2026 (USD Million)
  19. North America Public Blood Collection Centres Market, By Region, From 2021 to 2026 (USD Million)
  20. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  21. United States Apheresis Market, By Product, From 2021 to 2026 (USD Million)
  22. United States Apheresis Market, By Procedure, From 2021 to 2026 (USD Million)
  23. United States Apheresis Market, By Application, From 2021 to 2026 (USD Million)
  24. United States Apheresis Market, By Technology, From 2021 to 2026 (USD Million)
  25. United States Apheresis Market, By End user, From 2021 to 2026 (USD Million)
  26. Canada Apheresis Market, By Product, From 2021 to 2026 (USD Million)
  27. Canada Apheresis Market, By Procedure, From 2021 to 2026 (USD Million)
  28. Canada Apheresis Market, By Application, From 2021 to 2026 (USD Million)
  29. Canada Apheresis Market, By Technology, From 2021 to 2026 (USD Million)
  30. Canada Apheresis Market, By End user, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample